Trisomy for human chromosome 21 (Hsa21) results in Down syndrome (DS). The finished human genome sequence provides a thorough catalog of the genetic elements whose altered dosage perturbs development and function in DS. However, understanding how small alterations in the steady state transcript levels for <2% of human genes can disrupt development and function of essentially every cell presents a more complicated problem. Mouse models that recapitulate specific aspects of DS have been used to identify changes in brain morphogenesis and function. Here we provide a few examples of how trisomy for specific genes affects the development of the cortex and cerebellum to illustrate how gene dosage effects might contribute to divergence between the trisomic and euploid brains.
Introduction
Trisomy for human chromosome 21 (Hsa21) causes Down syndrome in approximately one out of every 800 live births [1] . Individuals with DS show a wide range of effects in many organ systems, some of which are congenital and some of which are progressive. These include cardiac malformations [2] , gastrointestinal anomalies [3] , craniofacial and skeletal anomalies [4, 5] , and contrasting cancer phenotypes, which include an increased frequency of childhood leukemia and reduced prevalence of many types of cancer in adults [6, 7] . There is broad variability in both the occurrence (penetrance) and severity (expressivity) of these phenotypes across the DS population. Since all individuals with DS have some degree of intellectual disability (ID), it is the most frequent genetic cause of ID, with intelligence quotients (IQs) that can range from mild to severe; the mean IQ in DS is 50 [8] . Studies in animal models and in people have uncovered cellular, physiological and functional changes that contribute to the etiology of cognitive deficits and provide the basis for emerging clinical trials aimed at improving cognitive abilities in DS [9] [10] [11] .
Central nervous system (CNS) abnormalities in DS seem to arise from a combination of abnormal development and functional changes that result directly from overexpression of genes in trisomic cells. Neuropathological changes found during late prenatal development in DS include delayed and disorganized cortical lamination [12] , a smaller and hypocellular hippocampal dentate gyrus [13] and hypomorphic cerebellum [14] [15] [16] [17] [18] . In the cerebral cortex, pyramidal neurons possess smaller dendritic arborizations [19] [20] [21] and there are fewer synapses in the prenatal DS brain [22, 23] . These deficits are followed postnatally by degeneration of cortical pyramidal neurons [24] , profound dendrite and synapse abnormalities [19, 21, 24, 25] and reductions in the total number of neurons in the hippocampus and cerebral cortex [13, 26] . Cerebellar development is delayed and ultimately appears to terminate prematurely. These findings indicate that prenatal changes in CNS growth and differentiation underlie many of the pathological abnormalities associated with ID in DS.
Several fundamental cellular growth mechanisms that are crucial for development are abnormal in DS. Specific changes have been reported for the cell cycle rate and progression in multiple organ systems, which suggests that the altered kinetics of cell production may contribute to many phenotypes. DNA synthesis and doubling times are both slower in DS fibroblasts [27, 28] and DS cerebral cortex contains less cyclin-dependent kinase [29] , which are indicative of lower replication rates. Recent studies have also shown that proliferation is abnormal in the developing DS forebrain [30] and cerebellum [31] . Many details regarding the molecular pathways underlying these phenotypes and how altered brain formation may lead to ID remain unclear. Here, we consider emerging data from mouse models of DS that demonstrate key deficiencies in neural stem and progenitor cell expansion and changes in the resulting specification of post-mitotic neurons and glial cells in the developing CNS. Elucidating the DS developmental brain abnormalities at the molecular level is essential for understanding the etiology of the postnatal cognitive disabilities.
Mouse models of DS and gene effects Cell intrinsic abnormalities caused by trisomy may be amplified by aberrant cell-cell interactions during development. These cascading effects pose challenges to understanding and ultimately treating the structural and functional defects observed in the postnatal brain [32, 33] . The complexity of these relationships in many organ systems cannot be recapitulated in a test tube or cell culture.
Mouse models of DS are trisomic for chromosome regions that show conserved synteny with Hsa21 (Figure 1) [34] . In comparison to human, orthologous mouse chromosome regions show minor differences in gene 
